[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350779-105":59,"doc-detail-350779-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","reactive-oxygen-species-in-breast-cancer-from-redox-dysregulation-to-ros-responsive-therapeutics-review-article","Reactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS‐Responsive Therapeutics - Review Article","","Reactive oxygen species (ROS) influence breast cancer through a dual mechanism: physiological ROS support normal signaling, while moderately increased ROS contribute to tumorigenesis via DNA damage and oncogene activation. The review systematizes redox dysregulation and oxidative stress pathways, then connects them to antioxidant defenses and the tumor microenvironment. It further summarizes ROS-targeting and ROS-responsive nanoagent therapeutic strategies aimed at limiting metastasis and overcoming multidrug resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/reactive-oxygen-species-in-breast-cancer-from-redox-dysregulation-to-ros-responsive-therapeutics-review-article/350779/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/reactive-oxygen-species-in-breast-cancer-from-redox-dysregulation-to-ros-responsive-therapeutics-review-article/350779.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What dual role do ROS play in breast cancer biology?","Question",{"text":112,"@type":113},"Physiological ROS sustain normal cellular signaling, while moderately elevated ROS promote tumorigenesis by driving DNA damage and activating proto-oncogenic processes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is redox dysregulation considered important in breast cancer progression?",{"text":117,"@type":113},"Redox dysregulation links oxidative stress signaling to key cellular outcomes that support tumor development and may affect clinical challenges such as metastasis and drug resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"How do ROS-responsive therapeutics and nanoagents relate to overcoming treatment resistance?",{"text":121,"@type":113},"ROS-responsive nanoagents are designed to exploit the cancer redox state, aiming to enhance therapeutic action and reduce issues such as acquired multidrug resistance within the tumor microenvironment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350779,1790819570,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Cell Biochemistry and Function   \nREVIEW ARTICLE   \nReactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS‐Responsive Therapeutics  \nMarija Nikolovska1,2  | Radoslav Stojchevski3,4,5  | Aleksandar Eftimov2  | Mitko Mladenov1  | Dimiter Avtanski3,4,6  | Nikola Hadzi‐Petrushev1   \n1Faculty of Natural Sciences and Mathematics, Institute of Biology, Ss. Cyril and Methodius University, Skopje, Macedonia | 2Faculty of Medicine, Institute of Pathology, Ss. Cyril and Methodius University, Skopje, Macedonia | 3Friedman Diabetes Institute, Lenox Hill Hospital, Northwell Health, New York, New York, USA | 4Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA | 5Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA | 6Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA  \nCorrespondence: Nikola Hadzi‐Petrushev ([nikola@pmf.ukim.mk](nikola@pmf.ukim.mk))  \nReceived: 16 April 2026 | Revised: 24 August 2026 | Accepted: 26 August 2026  \nKeywords: antioxidants | breast cancer | multidrug resistance | Nrf2 | oxidative stress | reactive oxygen species (ROS) | ROS‐responsive nanoagents | therapeutic strategies | tumor microenvironment  \nABSTRACT  \nBreast cancer is the most frequently diagnosed malignancy among women worldwide, with 2.3 million new cases and approximately 670,000 deaths reported in 2022 alone. Despite advances in therapy, metastasis and acquired drug resistance remain major clinical challenges. Reactive oxygen species (ROS) play a dual role in breast cancer biology: physiological levels sustain normal cellular signaling, moderately elevated levels promote tumorigenesis through DNA damage, proto‐oncogene  \n\n| Abbreviations: 1O2, singlet oxygen; 5hmC, 5‐hydroxymethylcytosine; 5mC, 5‐methylcytosine; 8‐oxo‐dG, 8‐oxo‐2′‐deoxyguanosine; AFMK, N1‐acetyl‐N2‐formyl‐ 5‐methoxykynuramine; AI, artificial intelligence; AIARS, Artificial Intelligence‐aided Redox Signature; AKT, protein kinase B; AMK, N1‐acetyl‐5‐methoxykynuramine; AP‐1, activator protein‐1; AQP3, aquaporin 3; AQP8, aquaporin 8; ARE, antioxidant response element; ATBC, Alpha‐Tocopherol Beta Carotene Cancer Prevention Study; ATP, adenosine triphosphate; BACH1, BTB domain and CNC homolog 1; Bax, Bcl‐2‐associated X protein; Bcl‐2, B‐cell lymphoma 2; Bcl‐xL, B‐cell lymphoma‐extra large; BER, Base excision repair; BLIS, basal‐like and immune‐suppressed; BRCA1, breast cancer susceptibility gene 1; BRD4, bromodomain‐containing protein 4; cAMP, cyclic adenosine monophosphate; CARET, Beta‐Carotene and Retinol Efficacy Trial; CAT, catalase; CBP, CREB‐binding protein; CCL26, C‐C motif chemokine ligand 26; COX‐2, cyclooxygenase‐2; CPT, camptothecin; Cul3, Cullin 3; CYP, cytochrome P450; DAMPs, damage‐associated molecular patterns; DLG, Asp‐Leu‐Gly motif; DNBS, 2,4‐ dinitrobenzenesulfonate; DOX, doxorubicin; EGFR, epidermal growth factor receptor; EMT, epithelial‐mesenchymal transition; ENTPD2, ectonucleoside triphosphate diphosphohydrolase 2; ER, estrogen receptor; ERK, extracellular signal‐regulated kinase; ERα, estrogen receptor alpha; ETC, electron transport chain; ETGE, Glu‐Thr‐ Gly‐Glu motif; FLIP, FLICE‐like inhibitory protein; FUDR, 5‐floxuridine; GCLC, glutamate‐cysteine ligase catalytic subunit; GCLM, glutamate‐cysteine ligase modifier subunit; GPx, glutathione peroxidase; GPX4, glutathione peroxidase 4; GR, glutathione reductase; GSH, glutathione; GSSG, glutathione disulfide; GST, glutathione S‐transferase; G‐CSF, granulocyte colony‐stimulating factor; H2O2, hydrogen peroxide; HA, hyaluronic acid; HAase, hyaluronidase; HDAC3, histone deacetylase 3; HER2, human epidermal growth factor receptor 2; HIF‐1α, hypoxia‐inducible factor 1‐alpha; HMGB1, high mobility group box 1; HO − 1, heme oxygenase‐1; HR, Homologous recombination; IAP, inhibitor of apoptosis protein; ICD, immunogenic cell death; ICI, immune checkpoint inhibitor; IKK, ","cbCaihSEmI9KD8Pb","https://ap.wps.com/l/cbCaihSEmI9KD8Pb","pdf",1834800,26,"English","# Abstract\n## Role of ROS in breast cancer biology\n## Redox dysregulation and oxidative stress pathways\n## Antioxidant defenses and tumor microenvironment\n## ROS-responsive nanoagent therapeutic strategies","[{\"question\":\"What dual role do ROS play in breast cancer biology?\",\"answer\":\"Physiological ROS sustain normal cellular signaling, while moderately elevated ROS promote tumorigenesis by driving DNA damage and activating proto-oncogenic processes.\"},{\"question\":\"Why is redox dysregulation considered important in breast cancer progression?\",\"answer\":\"Redox dysregulation links oxidative stress signaling to key cellular outcomes that support tumor development and may affect clinical challenges such as metastasis and drug resistance.\"},{\"question\":\"How do ROS-responsive therapeutics and nanoagents relate to overcoming treatment resistance?\",\"answer\":\"ROS-responsive nanoagents are designed to exploit the cancer redox state, aiming to enhance therapeutic action and reduce issues such as acquired multidrug resistance within the tumor microenvironment.\"}]","Reactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS‐Responsive Therapeutics - Review Article | PDF",1790091036,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89666653acac977dcc9c21a2615d03de.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd0a52e8d6219737c8b5d968fc60fe17.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ab2d7468b02d83154f82ec68fdffb22.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cf2d2367edfaf1573bcc0862bf920be.webp",980,1287]